Loading...

XML

Word

Printable

JSON

Specification:

Genomics Reporting (FHIR)
Raised in Version:

STU3
Work Group:

Clinical Genomics
Related Page(s):

genomics [deprecated]
Resolution Description:
Hide

PD-L1 is a tumormarker and not a CG scoped profile. Would fit into the cancer interop group. Profiles for TMB/MSI will be added to the IG:

http://build.fhir.org/ig/HL7/genomics-reporting/branches/tmb_msi/tmb.html

http://build.fhir.org/ig/HL7/genomics-reporting/branches/tmb_msi/msi.html
Show
PD-L1 is a tumormarker and not a CG scoped profile. Would fit into the cancer interop group. Profiles for TMB/MSI will be added to the IG: http://build.fhir.org/ig/HL7/genomics-reporting/branches/tmb_msi/tmb.html http://build.fhir.org/ig/HL7/genomics-reporting/branches/tmb_msi/msi.html
Resolution Vote:
James Jones / Bret Heale : 11-0-2
Change Category:
Enhancement
Change Impact:
Compatible, substantive

Currently MSI, TMB, PD-L1 can't be captured with the CG IG. As these a relevant observations in oncology CG reports these values should be supported